Portland, United States
Gabbi is positioning itself as a pioneer in women's health by focusing on early detection of breast cancer to render late-stage diagnoses obsolete. Founded in 2020, the company offers a groundbreaking breast cancer risk assessment and detection solution that claims to deliver immediate and accurate results for women across all demographics.
Operating within the Health Care, Health and Wellness, and Women's Health industries, Gabbi is headquartered in the United States. The company's mission aligns closely with current trends towards personalized and preventative healthcare solutions, potentially filling a critical gap in the market for accessible and effective breast cancer diagnostics.
The company's potential is underscored by its recent $25.00K Seed Round investment on 16 September 2024, backed by the Healthworx Accelerator. This initial funding, although modest, serves as a testament to its innovative approach and market readiness.
-logo.jpg "Michiana Hematology Oncology (MHO)"){kind=logo}